In melanoma and colorectal carcinoma, the G allele was associated with loss of p16INK4a and p14ARF expression, and in glioblastoma, CG genotype was associated with reduced p16INK4a and p14ARF gene dosage (13, 14, 17). Here, CDKN2A is linked to colorectal carcinoma.